n/a
Article Publish Status: FREE
Abstract Title:

Therapeutic Opportunities in Colorectal Cancer: Focus on Melatonin Antioncogenic Action.

Abstract Source:

Biomed Res Int. 2019 ;2019:9740568. Epub 2019 Sep 17. PMID: 31637261

Abstract Author(s):

Hucong Wu, Jiaqi Liu, Yi Yin, Dong Zhang, Pengpeng Xia, Guoqiang Zhu

Article Affiliation:

Hucong Wu

Abstract:

Colorectal cancer (CRC) influences individual health worldwide with high morbidity and mortality. Melatonin, which shows multiple physiological functions (e.g., circadian rhythm, immune modulation, and antioncogenic action), can be present in almost all organisms and found in various tissues including gastrointestinal tract. Notably, melatonin disruption is closely associated with the elevation of CRC incidence, indicating that melatonin is effective in suppressing CRC development and progression. Mechanistically, melatonin favors in activating apoptosis and colon cancer immunity, while reducing proliferation, autophagy, metastasis, and angiogenesis, thereby exerting its anticarcinogenic effects. This review highlights that melatonin can be an adjuvant therapy and be beneficial in treating patients suffering from CRC.

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.